OCLN and type 2 diabetes mellitus: And the results of both RT-qPCR and IHC showed that the expressions of ZO-1 and Occludin were significantly downregulated in the T2DM group but partially improved by GFP prevention (Figure 3a–d), indicating that GFP could enhance intestinal barrier function against T2DM in the rat model.